{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-084023","form_type":"8-K/A","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.191418+00:00","generated_at":"2026-05-31T20:08:32.044086+00:00","sec_items":["9.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Alaunos Therapeutics to effect 1-for-10 reverse stock split effective July 17, 2024","bullets":["Reverse split at 1-for-10 ratio; effective 5:00 p.m. Eastern on July 17, 2024.","Stock will trade split-adjusted on Nasdaq under symbol 'TCRT' starting July 18, 2024 with new CUSIP 98973P309.","Stockholder approval obtained at June 6, 2024 annual meeting; board set final ratio on June 26, 2024.","Equiniti Trust Company appointed as exchange agent to handle share conversion."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-084023","json":"https://secwatch.observer/filing/0000950170-24-084023.json","markdown":"https://secwatch.observer/filing/0000950170-24-084023.md","text":"https://secwatch.observer/filing/0000950170-24-084023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024084023/0000950170-24-084023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024084023/tcrt-20240716.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:08:32.044086+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}